Our findings demonstrate that increased NINJ2 expression in chemoresistant gastric cancer cells leads to upregulation of CD44, which in turn promotes vimentin expression and enhances invasive and mesenchymal characteristics. The gene discussed is CD44; the disease is gastric cancer.